BlackRock Institutional Trust Company, N.A. - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 40 filers reported holding TENAX THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$66,000
-18.5%
28,641
-10.0%
0.00%
Q2 2016$81,000
+24.6%
31,8300.0%0.00%
Q1 2016$65,000
-37.5%
31,8300.0%0.00%
Q4 2015$104,000
+9.5%
31,8300.0%0.00%
Q3 2015$95,000
-18.8%
31,8300.0%0.00%
Q2 2015$117,000
+12.5%
31,8300.0%0.00%
Q1 2015$104,000
-14.8%
31,8300.0%0.00%
Q4 2014$122,000
-2.4%
31,8300.0%0.00%
Q3 2014$125,00031,8300.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
FAS Wealth Partners, Inc. 1,291,932$466,0000.13%
Virtu Financial LLC 103,425$37,0000.00%
Verition Fund Management LLC 32,140$12,0000.00%
Baker Brothers Advisors 348,374$126,0000.00%
Cardinal Capital Management 10,000$3,0000.00%
TWO SIGMA SECURITIES, LLC 21,500$8,0000.00%
BANK OF AMERICA CORP /DE/ 1,079$00.00%
WELLS FARGO & COMPANY/MN 1$00.00%
NORTHERN TRUST CORP 51,187$18,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 87,632$31,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders